During the past decade, Centro Medico Imbanaco de Cali S.A ( Site 3404) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Medico Imbanaco de Cali S.A ( Site 3404)" are "Pulmonary Arterial Hypertension" (2 trials) and "PAH" (1 trials). Many other conditions were trialed in "Centro Medico Imbanaco de Cali S.A ( Site 3404)" in a lesser frequency.

Most popular intervention types in "Centro Medico Imbanaco de Cali S.A ( Site 3404)" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sotatercept" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Imbanaco de Cali S.A ( Site 3404)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Medico Imbanaco de Cali S.A ( Site 3404)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Medico Imbanaco de Cali S.A ( Site 3404), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Imbanaco de Cali S.A ( Site 3404), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".